A worldwide call to action, spearheaded by Western University researcher Dr. Vladimir Hachinski, is calling for more attention to the link between reducing strokes and preventing dementia.
Approximately 747,000 Canadians live with dementia, including Alzheimer’s diseases, which represents 14.9 per… Continue Reading

online now! Click here to read. The European Journal of Neurology is free of charge for EAN members! Log-in on www.eaneurology.org. If you encounter difficulties accessing the Journal, please contact headoffice@eaneurology.org Just published!  Practical recommendations for the process of proposing,… Continue Reading

Register to the EAN Congress 2016 in Copenhagen only via www.eaneurology.org and www.eaneurology.org/copenhagen2016! Any congress registration purchased via a different website will be invalid. If you are not sure where to register, please contact the EAN Head Office at headoffice@eaneurology.org.… Continue Reading

Many political decisions within the health system are critical depending on the number of patients affected by a particular disease group and hence which discipline of medicine is responsible for the care of these patients. This applies for budgets for health care, number of beds for a particular disease group, overall budget for a discipline within a hospital, budgets for out- or inpatients care, but also percentage of research money which goes into particular fields of medical research. Also, the general public counts on these measures because mortality, morbidity and costs of disease are important to determine the importance of a disease group and usually, the higher the numbers the more important is the disease.

David Vodušek (DV): As President of the American Academy of Neurology (AAN) and active neuro-oncologist you are confronted with the full panorama of neurological sciences. How will you bridge the very specific and the very broad? Terrence Cascino (TC): The Academy exists because of the enormous intellect among the hundreds of volunteer neurologists who help to provide the unparalleled programs, products, and services to our more than 28,000 members around the world. These volunteers represent some of the best and brightest neurologists and are knowledgeable on the hundreds of neurologic diseases encountered in clinical practice by our members.

"Horizon 2020 is the financial instrument implementing the Innovation Union, a Europe 2020 flagship initiative aimed at securing Europe's global competitiveness", Thomas Skordas. Elena Moro (EM): Can you briefly illustrate to the Neuropenews readers what are the FET – Future and Emerging Technologies – actions and which place do they take within the EC’s H2020 programme? Thomas Skordas (TS): FET – Future and Emerging Technologies – is part of the "Excellent Science" pillar of Horizon 2020. The other components of this pillar are the "European Research Council (ERC)", the "Marie Skłodowska-Curie actions" and the "Research infrastructures" actions. Altogether, these four components aim to reinforce, widen and extend the excellence of the Union's science base and ensure a supply of world-class research and talent pursuing to secure Europe's long term competitiveness and well-being.

eBbrain e-learning programme (http://www.ebrainjnc.com) is a gold standard in interactive online learning tool for professionals in neuroscience. The vast majority of important neurological topics are already covered by eBrain. The others are in the process of developing. The module on… Continue Reading

For almost 100 years there have been Danish neurologists with a dedicated interest in migraine and other headache disorders. 50 years ago the champion was Dr. Dalsgaard-Nielsen and my mentor Erik Skinhøj got his interest in migraine during his clinical training with Dalsgaard-Nielsen.

by Delia Lenzi It is well known in the scientific community that the connectomes will in the near future deeply influence our vision of how the brain works. In this very comprehensive article, published in Nature early this month, Amber… Continue Reading

For November 2015, we have selected: Kalra L, Irshad J, Simpson J, et al., on behalf of the STROKE-INF Investigators. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled trial. Lancet Neurology 2015; September 4. Dysphagia is common after a stroke, and associated with an increased risk of pneumonia and mortality. However, the use of antibiotics to prevent post-stroke pneumonia has been controversial.

EAN unites and supports neurologists across the whole of Europe and aims at strengthening collaboration between clinical neurology and related scientific societies. We are delighted to hereby announce that EAN and the European Stroke Organisation have signed a letter of… Continue Reading

I spent my EFNS scientific fellowship period at the University College London (UCL) in the United Kingdom between 1st April 2014 and 31st March 2015, under the guidance of Professor Martin M Brown. The title of my research project was… Continue Reading

by Julia Mayer For the first time the EAN regional teaching course “travelled” to Montenegro, to the lovely town of Budva, at the coast, just one hour from the capital Podgorica.
The course was organised by Professor Slavica Vujisic, President… Continue Reading

by Antonella Macerollo I attended the Regional Teaching Course of the European Academy of Neurology that took place from 9-11 October 2015 in Budva, Montenegro and represented the European Association of Young Neurologists and Trainees (EAYNT). The course covered several… Continue Reading

by Slavica Vujisic and Sanja Vodopic The Regional Teaching Course of the European Academy of Neurology took place on October 9th -11th, 2015 in Budva, Montenegro. It was the first time the regional teaching course was organised in our country.… Continue Reading